Hofland LJ - Search Results

1

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R, de Jong FH, van der Lely AJ, de Herder WW, Hofland LJ, Lamberts SW. Feelders RA, et al. Among authors: hofland lj. N Engl J Med. 2010 May 13;362(19):1846-8. doi: 10.1056/NEJMc1000094. N Engl J Med. 2010. PMID: 20463350 Clinical Trial. No abstract available.

2

The interrelationship between the anti-mitotic action of the somatostatin analog octreotide and that of cytostatic drugs and suramin.

Lamberts SW, van Koetsveld P, Hofland LJ. Lamberts SW, et al. Among authors: hofland lj. Int J Cancer. 1991 Jul 30;48(6):938-41. doi: 10.1002/ijc.2910480623. Int J Cancer. 1991. PMID: 1860738

3

Percoll density gradient centrifugation of rat pituitary tumor cells: a study of functional heterogeneity within and between tumors with respect to growth rates, prolactin production and responsiveness to the somatostatin analog SMS 201-995.

Hofland LJ, van Koetsveld PM, Lamberts SW. Hofland LJ, et al. Eur J Cancer. 1990 Jan;26(1):37-44. doi: 10.1016/0277-5379(90)90254-q. Eur J Cancer. 1990. PMID: 2138476

4

The effect of clozapine on prolactin secretion at the level of the lactotroph.

Lamberts SW, van Koetsveld PM, Hofland LJ. Lamberts SW, et al. Among authors: hofland lj. Life Sci. 1990;46(14):1013-9. doi: 10.1016/0024-3205(90)90025-m. Life Sci. 1990. PMID: 2325501 Free article.

5

The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.

Lamberts SW, den Holder F, Hofland LJ. Lamberts SW, et al. Among authors: hofland lj. Endocrinology. 1989 Feb;124(2):905-11. doi: 10.1210/endo-124-2-905. Endocrinology. 1989. PMID: 2492219

6

A close correlation between the inhibitory effects of insulin-like growth factor-I and SMS 201-995 on growth hormone release by acromegalic pituitary tumours in vitro and in vivo.

Lamberts SW, van Koetsveld P, Hofland L. Lamberts SW, et al. Clin Endocrinol (Oxf). 1989 Oct;31(4):401-10. doi: 10.1111/j.1365-2265.1989.tb01264.x. Clin Endocrinol (Oxf). 1989. PMID: 2627746

7

Octreotide, but not bromocriptine, increases circulating insulin-like growth factor binding protein 1 levels in acromegaly.

de Herder WW, Uitterlinden P, van der Lely AJ, Hofland LJ, Lamberts SW. de Herder WW, et al. Among authors: hofland lj. Eur J Endocrinol. 1995 Aug;133(2):195-9. doi: 10.1530/eje.0.1330195. Eur J Endocrinol. 1995. PMID: 7544670 Clinical Trial.

8

IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly.

de Herder WW, van der Lely AJ, Janssen JA, Uitterlinden P, Hofland LJ, Lamberts SW. de Herder WW, et al. Among authors: hofland lj. Clin Endocrinol (Oxf). 1995 Oct;43(4):501-5. doi: 10.1111/j.1365-2265.1995.tb02623.x. Clin Endocrinol (Oxf). 1995. PMID: 7586626

9

Somatostatin receptors: clinical implications for endocrinology and oncology.

Lamberts SW, de Herder WW, van Koetsveld PM, Koper JW, van der Lely AJ, Visser-Wisselaar HA, Hofland LJ. Lamberts SW, et al. Among authors: hofland lj. Ciba Found Symp. 1995;190:222-36; discussion 236-9. doi: 10.1002/9780470514733.ch14. Ciba Found Symp. 1995. PMID: 7587649 Review.

10

Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes.

Hofland LJ, Visser-Wisselaar HA, Lamberts SW. Hofland LJ, et al. Biochem Pharmacol. 1995 Jul 31;50(3):287-97. doi: 10.1016/0006-2952(95)00066-9. Biochem Pharmacol. 1995. PMID: 7646531 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters